Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-08-057839
Filing Date
2008-10-29
Accepted
2008-10-29 18:46:43
Documents
1
Period of Report
2008-10-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3899
  Complete submission text file 0001209191-08-057839.txt   5905
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Issuer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 22026 20TH AVENUE SE BOTHELL WA 98021
Business Address SONUS PHARMACEUTICALS INC 22026 20TH AVE SE BOTHELL WA 98021 4254879500
MARTINO MICHAEL A (Reporting) CIK: 0001238250 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21243 | Film No.: 081148849